Sort
50,496 grants matching “lung cancer”
Signal Transduction by Non-transmembrane PTPs
$502,926Benjamin G. Neel · Beth Israel Deaconess Medical Center · R37 · FY2007 · CA
PROMINENT - IARC
$502,922Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2024 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$502,902Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
$502,882Moumita Ghosh · University Of Colorado Denver · R01 · FY2021 · CA
Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver
$502,844Gikas S Mageras · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Genetically Modified Gamma Delta T Cells to Target SIV Reservoirs
$502,807Namita Rout · Tulane University Of Louisiana · R33 · FY2021 · AI
LACE-Bio-II: Identification, validation and implementation of prognostic and/or p
$502,749Lesley Katie Seymour · Queen'S University At Kingston · R01 · FY2016 · CA
Molecular and biochemical basis of Lymphangioleiomyomatosis
$502,724John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · HL
Molecular and biochemical basis of Lymphangioleiomyomatosis
$502,724John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · HL
UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK
$502,687Philip Lazarus · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · DE
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$502,619Nir Hacohen · Broad Institute, Inc. · R01 · FY2019 · CA
Biomarker Development Lab
$502,606Steven M. Dubinett · Boston University Medical Campus · U2C · FY2022 · CA
Targeted Inhibition in Leukemia
$502,537Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Developmental Funds
$502,500Eric P Winer · Yale University · P30 · FY2025 · CA
Corrective Image Reconstruction Methods for ECT
$502,465Benjamin M Tsui · Johns Hopkins University · R01 · FY2008 · EB
Mechanisms of enhancer regulation in leukemia
$502,459Iannis Aifantis · New York University School Of Medicine · R01 · FY2020 · CA
Mechanisms of enhancer regulation in leukemia
$502,459Iannis Aifantis · New York University School Of Medicine · R01 · FY2021 · CA
Lineage heterogeneity and plasticity in lung cancer
$502,376Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.
$502,362Leah J Siskind · University Of Louisville · R01 · FY2022 · DK
miR-155 targeted therapeutics for precision medicine in lung cancer
$502,255George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERS
$502,200Jenny T Mao · University Of California Los Angeles · U01 · FY2007 · CA
Functional role of the MUC1-C oncoprotein in non-small cell lung cancer
$502,149Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Stress responses drive resistance and shape tumor evolution in EGFR mutant lung cancer
$502,135Sourav Bandyopadhyay · University Of California, San Francisco · R01 · FY2020 · CA
The role of mitochondrial glutathione homeostasis in tumor formation
$502,064Kivanc Birsoy · Rockefeller University · R01 · FY2023 · CA
Impact of Cryptococcus Titan Cells on Pathogenesis.
$502,026Kirsten Nielsen · University Of Minnesota · R01 · FY2021 · AI